At the 2015 annual EHA meeting in Vienna, one session was dedicated to the ‘treatment and outcome in non-Hodgkin lymphoma’. Topics included, among others, the long-term outcome in early stage extra-nodal marginal zone lymphoma, a subgroup analysis of the MCL-002 (SPRINT) study, the PINK/PINK-E prognostic model for extra nodal NK/T-cell lymphoma.
(BELG J HEMATOL 2015;6(3):101–3)
* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Hematology in Belgium and Luxembourg with prescription authorisation)
** (for healthcare professionals with prescribing authorisation working outside the field of Hematology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Hematology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)
Top
